These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment. Yong VW, Perry TL, Krisman AA. Neurosci Lett; 1986 Jan 02; 63(1):56-60. PubMed ID: 3485266 [Abstract] [Full Text] [Related]
3. Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP). Martinovits G, Melamed E, Cohen O, Rosenthal J, Uzzan A. Neurosci Lett; 1986 Aug 29; 69(2):192-7. PubMed ID: 3489911 [Abstract] [Full Text] [Related]
4. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse. Perry TL, Yong VW, Jones K, Wall RA, Clavier RM, Foulks JG, Wright JM. Neurosci Lett; 1985 Aug 05; 58(3):321-6. PubMed ID: 3876525 [Abstract] [Full Text] [Related]
5. Alpha-tocopherol and beta-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Perry TL, Yong VW, Hansen S, Jones K, Bergeron C, Foulks JG, Wright JM. J Neurol Sci; 1987 Nov 05; 81(2-3):321-31. PubMed ID: 3121800 [Abstract] [Full Text] [Related]
6. 4-phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets. Perry TL, Jones K, Hansen S, Wall RA. Neurosci Lett; 1987 Mar 20; 75(1):65-70. PubMed ID: 3106859 [Abstract] [Full Text] [Related]
7. Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2(PLG; MIF-1). Sheng JG, Xu DL, Yu HZ, Xu XR, Tang QM. Life Sci; 1987 May 18; 40(20):2007-10. PubMed ID: 2437428 [Abstract] [Full Text] [Related]
8. Paraquat and two endogenous analogues of the neurotoxic substance N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouse. Perry TL, Yong VW, Wall RA, Jones K. Neurosci Lett; 1986 Sep 12; 69(3):285-9. PubMed ID: 3489912 [Abstract] [Full Text] [Related]
9. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC. Nature; 1986 Sep 12; 311(5985):467-9. PubMed ID: 6332989 [Abstract] [Full Text] [Related]
10. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress. Rojas P, Serrano-García N, Mares-Sámano JJ, Medina-Campos ON, Pedraza-Chaverri J, Ogren SO. Eur J Neurosci; 2008 Jul 12; 28(1):41-50. PubMed ID: 18662333 [Abstract] [Full Text] [Related]
11. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogues on the dopaminergic nigrostriatal pathway in mice. Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC. Neurosci Lett; 1985 Jul 04; 58(1):133-7. PubMed ID: 3876523 [Abstract] [Full Text] [Related]
12. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra. Ricaurte GA, Irwin I, Forno LS, DeLanney LE, Langston E, Langston JW. Brain Res; 1987 Feb 10; 403(1):43-51. PubMed ID: 3493827 [Abstract] [Full Text] [Related]
13. Attenuation of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine induced nigrostriatal toxicity in mice by N-acetyl cysteine. Sharma A, Kaur P, Kumar V, Gill KD. Cell Mol Biol (Noisy-le-grand); 2007 Apr 15; 53(1):48-55. PubMed ID: 17519111 [Abstract] [Full Text] [Related]
14. Synthesis and toxicity toward nigrostriatal dopamine neurons of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogues. Fries DS, de Vries J, Hazelhoff B, Horn AS. J Med Chem; 1986 Mar 15; 29(3):424-7. PubMed ID: 3485197 [Abstract] [Full Text] [Related]
15. Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse. Heikkila RE, Sieber BA, Manzino L, Sonsalla PK. Mol Chem Neuropathol; 1989 Jun 15; 10(3):171-83. PubMed ID: 2669769 [No Abstract] [Full Text] [Related]
16. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment. Ricaurte GA, Langston JW, Delanney LE, Irwin I, Peroutka SJ, Forno LS. Brain Res; 1986 Jun 18; 376(1):117-24. PubMed ID: 3487376 [Abstract] [Full Text] [Related]
17. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L, Garris BL, Garris DR, Lau YS. Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572 [Abstract] [Full Text] [Related]
18. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease. Jenner P, Marsden CD. J Neural Transm Suppl; 1986 Jun 19; 20():11-39. PubMed ID: 3091760 [Abstract] [Full Text] [Related]
19. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum. Kawasaki T, Ishihara K, Ago Y, Baba A, Matsuda T. J Pharmacol Exp Ther; 2007 Jul 19; 322(1):274-81. PubMed ID: 17429058 [Abstract] [Full Text] [Related]
20. Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mouse brain by piroheptine and trihexyphenidyl. Saitoh T. J Neurol Sci; 1988 Feb 19; 83(2-3):161-6. PubMed ID: 3258627 [Abstract] [Full Text] [Related] Page: [Next] [New Search]